i-Base

HTB 2024: Glasgow 2024, UNHEARD by Dr Rageshri and latest UK statistics

LATEST NEWS

US NIH announces that a second study of the antiviral tecovirimat has been stopped early. No benefit was seen in either pain relief or earlier recovery.

Short review of these new US guidelines that include information about weight changes and support some easier dosing options for PrEP.

Review of a new book carefully reviewing the factors that sustain inequity of healthcare in the UK and globally, from one of the UKs leading and highly respected HIV doctors.

ALL REPORTS

All back issues

Please subscribe to receive a free email every 3-4 weeks of the latest news.

Reports will also be posted to social media at the same time.

Twitter (x)        Facebook        Instagram